Efficacy of vedolizumab and methotrexate combination in patients with moderate to severe pediatric inflammatory bowel disease

Trial Profile

Efficacy of vedolizumab and methotrexate combination in patients with moderate to severe pediatric inflammatory bowel disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 May 2017

At a glance

  • Drugs Vedolizumab (Primary) ; Methotrexate
  • Indications Inflammatory bowel diseases
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 May 2017 New trial record
    • 09 May 2017 Results presented at the Digestive Disease Week 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top